Volver a Agendas
Session Chair(s)
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Koichiro Yuji, MD, PhD, FACP
Project Associate Professor, The Institute of Medical Science
Japan
Speaker(s)
"Do all patients in the phase I trials need to be hospitalized? - Domestic but outstanding issues for globalization in Japan - "
Akihiko Shimomura, MD
National Cancer Center Hospital, Japan
Attending Staff, Dept. of Experimental Therapeutics/Breast and Medical Oncology
Meaningful Use of DPC Claim database for Postmarketing Surveillance of New Drugs
Masahiro Inoue, MD, PhD
Ota Memorial Hospital, Japan
Division Manager
Study on Drug Lag between Japan and the US in Oncology Drugs. Considerations of Changes and Factors Affecting Difference with the US
Hideki Maeda, PhD
Meiji Pharmaceutical University, Japan
Professor, Department of Regulatory Science
¿Tiene una cuenta?